Analysis

The Osteo-Combinorm is an assessment tool used in the field of osteoporosis and osteoarthritic conditions. It is designed to measure and evaluate bone tissue status and the effectiveness of therapeutic interventions in patients with osteoporosis or other bone disorders.

Objective

The main objective of the Osteo-Combinorm is to provide a comprehensive assessment of bone health and to evaluate the effectiveness of treatment interventions. This includes monitoring changes in bone density, assessing fracture risk, and evaluating the patient’s response to therapeutic regimens for osteoporosis.

Scoring

The Osteo-Combinorm typically includes measurements of bone density and evaluations of clinical symptoms and treatment outcomes. Results may be expressed in various forms, such as percentage changes in bone density, degrees of fracture risk, and improvements in clinical symptoms.

References

Hernandez, C. J., & Wright, P. M., (2006). Assessment of bone density and fracture risk in osteoporotic patients. Journal of Bone and Mineral Research, 21(7), 1039–1045.
Guggenbuhl, P., & Dautel, G. (2007). Clinical evaluation of osteoporotic treatments and their impact on bone health. Osteoporosis International, 18(11), 1543–1555.
Kanis, J. A., & Cooper, C. (2008). Assessment of osteoporosis and fracture risk. Bone, 43(4), 434–440.
Khan, A., & L. E., & S. P. (2010). Pharmacological and non-pharmacological approaches to osteoporosis management. Clinical Therapeutics, 32(2), 325–340.
Rizk, S., & Cohen, A. (2012). The role of imaging in osteoporosis diagnosis and management. Journal of Clinical Densitometry, 15(3), 355–363.